NCT00709813 Study to Test a Computer-assisted Support System to Improve Patient-centered Care and Symptom Relief in Cancer Patients Status COMPLETED Phase NA
NCT00705250 Bendamustine HCL in Relapsed and Primary Refractory Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT00698685 Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation Status TERMINATED Phase PHASE2
NCT00695422 Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials Status COMPLETED Phase N/A
NCT00695409 Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BEAM Followed By ASCT For Relapsed B-Cell Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT00691652 Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma Status TERMINATED Phase PHASE1/PHASE2
NCT00691015 Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant Status COMPLETED Phase PHASE2
NCT00690560 Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00689845 Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma Status UNKNOWN Phase NA
NCT00688415 Safety and Pharmacologic Study of VTX-2337 in Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT00686465 Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study Status COMPLETED Phase NA
NCT00678327 Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma Status COMPLETED Phase PHASE3
NCT00677105 A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma. Status COMPLETED Phase PHASE1
NCT00674024 Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Function Status COMPLETED Phase PHASE1
NCT00671112 Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma Status TERMINATED Phase PHASE1
NCT00670358 Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00669812 High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma Status UNKNOWN Phase PHASE2
NCT00669318 Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Status COMPLETED Phase PHASE2